Evidence map›Paper›PMID 36596217›Full record

ReviewJournal of immunology (Baltimore, Md. : 1950)2023

Complement: The Road Less Traveled.

Claudia Kemper, Viviana P Ferreira, Jeanne T Paz, V Michael Holers, Michail S Lionakis, Jessy J Alexander

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of immunology (Baltimore, Md. : 1950), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Therapeutics for Alcohol-Associated Liver Disease.Annual review of pharmacology and toxicology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Role of Complement in Liver Diseases.Seminars in liver disease · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Claudia KemperComplement and Inflammation Research Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.ORCID 0000-0003-4196-1417
Viviana P FerreiraDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine, Toledo, OH.ORCID 0000-0001-8923-5671
Jeanne T PazGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco CA.
V Michael HolersDivision of Rheumatology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.
Michail S LionakisFungal Pathogenesis Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and.ORCID 0000-0003-4994-9500
Jessy J AlexanderDepartment of Medicine, University at Buffalo, Buffalo, NY.ORCID 0000-0001-8074-9713
National Institutes of Health · USGladstone Institutes · USUniversity at Buffalo, State University of New York · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Toledo Medical Center · US

Funding

Immunopathogenesis of Fungal InfectionsZIAAI001175 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI LIONAKIS, MICHAIL · 2012 to 2025
$23.9M
The role of the intracellular complement system - the complosome - in Th1 biologyZIAHL006223 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KEMPER, CLAUDIA · 2017 to 2025
$16.9M
Complement in the Pathogenesis of Autoimmune ArthritisR01AR051749 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI Vernon Michael Holers · 2004 to 2026
$6.7M
The role of the intracellular complement system - the complosome - in monocytesZIAHL006222 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI KEMPER, CLAUDIA · 2017 to 2025
$3.2M
Role of complement regulator properdin in the interaction between platelets and lR01HL112937 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI FERREIRA, VIVIANA P · 2014 to 2018
$1.9M
Role of Thalamus in Post-stroke epileptogenesisR00NS078118 · NINDS · J. DAVID GLADSTONE INSTITUTES · PI PAZ, JEANNE T · 2014 to 2016
$747k
Mechanisms of Complement Dependent Immune Complex-Mediated GlomerulonephritisR01DK111222 · NIDDK · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI ALEXANDER, JESSY J · 2018 to 2020
$712k
Role of Thalamus in Post-stroke epileptogenesisK99NS078118 · NINDS · STANFORD UNIVERSITY · PI PAZ, JEANNE T · 2012 to 2013
$179k
INHIBITION OF PLASMODIUM/HEPATOCYTE INTERACTIONK11AI001175 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SINNIS, PHOTINI · 1993 to 1997
–
Intramural NIH HHS ZIA AI001175Intramural NIH HHS ZIA HL006223NHLBI NIH HHS R01 HL112937NIAID NIH HHS K11 AI001175NIAMS NIH HHS R01 AR051749NIDDK NIH HHS R01 DK111222NINDS NIH HHS K99 NS078118NINDS NIH HHS R00 NS078118
6 · The paper itself

Abstract

The complement field has recently experienced a strong resurgence of interest because of the unexpected discovery of new complement functions extending complement's role beyond immunity and pathogen clearance, a growing list of diseases in which complement plays a role, and the proliferation of complement therapeutics. Importantly, although the majority of complement components in the circulation are generated by the liver and activated extracellularly, complement activation unexpectedly also occurs intracellularly across a broad range of cells. Such cell-autonomous complement activation can engage intracellular complement receptors, which then drive noncanonical cell-specific effector functions. Thus, much remains to be discovered about complement biology. In this brief review, we focus on novel noncanonical activities of complement in its "classic areas of operation" (kidney and brain biology, infection, and autoimmunity), with an outlook on the next generation of complement-targeted therapeutics.

Indexed as

Complement ActivationComplement System ProteinsComplement System Proteins

Identifiers

PMID36596217
PMCPMC10038130
OpenAlexW4313451585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.